DENOSUMAB is a medication used to treat osteoporosis in postmenopausal women, men at high risk of fractures, and those who have not responded well to other treatments. It works by slowing bone breakdown and increasing bone mass.
DENOSUMAB is beneficial for:
DENOSUMAB is a monoclonal antibody that inhibits a protein called RANKL, which is involved in bone breakdown. By blocking RANKL, DENOSUMAB helps increase bone density and reduce the risk of fractures.
During your first visit:
DENOSUMAB is administered as an injection under the skin (subcutaneously). It is typically given once every six months.
Common side effects of DENOSUMAB may include:
Serious side effects such as low calcium levels, infections, and allergic reactions are rare but possible. Your healthcare provider will discuss potential risks and how to manage them.
DENOSUMAB treatment is usually recommended for as long as your doctor determines it is necessary to manage your osteoporosis effectively. It is important to follow your healthcare provider's recommendations and attend regular follow-up appointments to monitor your bone health and response to treatment.
Your healthcare provider will review your current medications and health conditions to ensure there are no interactions with DENOSUMAB. It's important to inform your doctor about all medications, including over-the-counter drugs and supplements.
DENOSUMAB has been shown to significantly increase bone density and reduce the risk of fractures in clinical studies. Individual responses to treatment may vary, and it is important to follow your treatment plan as prescribed by your healthcare provider.
To optimize the benefits of DENOSUMAB and promote bone health:
You can schedule an appointment by contacting our clinic via phone, email, or through our website. Our staff will assist you in finding a convenient time for your visit and answer any additional questions you may have about DENOSUMAB treatment.